• Abacavir hypersensitivity / HLA-B histocompatibility type
• Androgen receptor (DHTR)
• ATP-binding CASSETTE C2 (ABC transporter C2, MRP2)
• Butyrylcholinesterase deficiency (BCHE, Pseudocholinesterase)

• BRAF mutations in solid tumors (V600E)

• Carboxylesterase 1 deficiency
• Catechol-O-methyltransferase
• Coumarin resistance
• Cumarin-Sensitivity
• Cytochromes P 450 (overview)

• Dihydropyrimidine dehydrogenase deficiency (DPD), 5-fluorouracil toxicity

• ESR1 and PIK3CA Liquid Biopsy before ORSERDU® (Elacestrant) or Piqray® (Alpelisib) therapy
• ETV6-PDGFRB fusion gene

• FIP1L1/PDGFRA fusion gene (microdeletion 4q12)

• Glucose-6-phosphate-dehydrogenase deficiency (acute hemolytic anaemia)
• Glutathione S-transferase (M1, P1, T1)

• Irinotecan-intolerance

• MTHFR (5,10-Methylenetetrahydrofolate reductase deficiency)
• Gilbert syndrome / Meulengracht disease
• Methylation analysis of promoter methylation status of DNA-Mismatch-Repeair genes MLH1, MLH3, MSH2, MSH3, MSH6, MGMT and PMS2 in suspected HNPCC/Lynch-Syndrome
• MSI - Microsatelliteinstability of a colorectal cancer
• Multidrug resistance protein 1

• N-Acetyltransferase 1
• N-Acetyltransferase 2 (Acetylation, slow)
• NAD(P)H: Chinonoxidoteductase-1 (NQO1) *2 (609C>T)

• Organic anion transporter 1B1

• Paraoxonase 1

• Statin intolerance
• Sulfotransferase 1A1
• Superoxide dismutase 2 (rs4880)

• Thiopurine S-methyltransferase deficiency